NASDAQ:STAB Statera Biopharma (STAB) Stock Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free STAB Stock Alerts $0.0006 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.04Volume307 shsAverage Volume10,594 shsMarket Capitalization$32,796.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends Get Statera Biopharma alerts: Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> About Statera Biopharma Stock (NASDAQ:STAB)Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.Read More STAB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STAB Stock News HeadlinesMay 19, 2024 | foxnews.comDog-walking NY couple turns table on would-be mugger who was hospitalized with stab wounds: videoMay 8, 2024 | bbc.co.ukBridgend: Wife begged ex-councillor to end stab attack - courtApril 18, 2024 | morningstar.comStatera BioPharma Inc Ordinary SharesApril 12, 2024 | finance.yahoo.comCRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAApril 7, 2024 | bbc.comArrests after man found with serious stab injuriesApril 4, 2024 | bbc.comPolice appeal after man found with stab injuriesFebruary 25, 2024 | wsj.comAEON Biopharma Inc.January 30, 2024 | investing.comMereo BioPharma Group PLC ADR (MREO)December 14, 2023 | bbc.comCrookes curry house knife used to stab teenager to deathDecember 9, 2023 | bbc.comLeeds stab death: Police name victim of Chapeltown attackNovember 25, 2023 | bbc.co.ukTwo boys, 12, in court charged with Wolverhampton stab murderNovember 25, 2023 | bbc.co.ukWolverhampton: Two boys, 12, arrested over stab murder of manNovember 11, 2023 | morningstar.comARCA biopharma Inc ABIONovember 10, 2023 | nbcnews.comCornell University student threatened to stab and rape Jewish students and ‘shoot up’ school, prosecutors sayOctober 31, 2023 | morningstar.comPOINT Biopharma Global Inc Ordinary Shares PNTOctober 29, 2023 | nypost.comElianne Andam died from ‘multiple stab wounds’ in ‘brutal’ attackOctober 23, 2023 | benzinga.comSutro Biopharma Stock (NASDAQ:STRO), Analyst Ratings, Price Targets, PredictionsOctober 12, 2023 | bbc.comMurder arrest over man's stab death in HaringeyOctober 11, 2023 | mirror.co.ukBristol stab death victim's family 'heartbroken' as woman in 'hate crime' arrestOctober 6, 2023 | bbc.co.ukHigh Wycombe: Two men held over teen's stab deathJuly 31, 2023 | mirror.co.ukChilling moment teen killers stab wrong boy with ninja sword in mistaken identity murderMay 7, 2023 | abcnews.go.comAutopsy: Stab wounds to heart, lungs killed Cash App founderMay 2, 2023 | news.yahoo.com‘Don’t let him stab him:’ Police release video of suspect shot, killed attempting to stab police K-9March 15, 2023 | finance.yahoo.comStatera Biopharma Signs Letter of Intent for Merger with Worksite LabsJanuary 27, 2023 | seekingalpha.comSTAB Statera Biopharma, Inc.See More Headlines Receive STAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:STAB CUSIPN/A CIK1318641 Webwww.staterabiopharma.com Phone(888) 613-8802Fax716-849-6820Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.49 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares54,660,000Free Float51,656,000Market Cap$32,796.00 OptionableNot Optionable Beta0.45 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Michael Kevin Handley (Age 52)CEO, President & Chairman of the Board Comp: $2.87MMr. Christopher Zosh (Age 48)Executive VP of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer Dr. Robert W. Buckheit Jr. (Age 64)Ph.D., Chief Technology Officer Key CompetitorsCalithera BiosciencesNASDAQ:CALAScopus BioPharmaNASDAQ:SCPSNVN LiquidationNASDAQ:NOVNQEvelo BiosciencesNASDAQ:EVLOLAVA TherapeuticsNASDAQ:LVTXView All Competitors STAB Stock Analysis - Frequently Asked Questions How have STAB shares performed in 2024? Statera Biopharma's stock was trading at $0.0006 on January 1st, 2024. Since then, STAB shares have increased by 0.0% and is now trading at $0.0006. View the best growth stocks for 2024 here. How do I buy shares of Statera Biopharma? Shares of STAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:STAB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Statera Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.